Patent · US Active

Bisphosphonate quinolone conjugates and uses thereof

US11840549B2 · kind B2 · utility

0Cited by

2References

27Claims

0Family size

Assignees

BIOVINC, LLC · US
University of Southern California · US

Inventors

Frank Hallock Ebetino · Venice, US
Shuting Sun · Los Angeles, US
Mark Walden Lundy · Cincinnati, US
Charles E. McKenna · Santa Monica, US
Eric Richard · Pasadena, US
Parish Sedghizadeh · Los Angeles, US
Keivan Sadrerafi · Pasadena, US
Philip T. Cherian · Pasadena, US

Key dates

Filing date	Dec 11, 2020
Grant date	Dec 12, 2023
Priority date	—
Expiry date	Apr 12, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F9/6561
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are bisphosphonate quinolone compounds, conjugates and pharmaceutical formulations thereof that can include a bisphosphonate and a quinolone, where the quinolone can be releasably coupled to the bisphosphonate. Also provided herein are methods of making and methods of using the bisphosphonate quinolone compounds, conjugates and pharmaceutical formulations thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.